# Analysis of Revascularization in Ischemic Stroke With EmboTrap

Study · id `cardio:ct-nct02488915` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02488915](<https://clinicaltrials.gov/study/NCT02488915>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02488915

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.

## Technical summary

Registry record NCT02488915. Allocation not applicable; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2017-05 (actual). Results posted on 2018-07-13.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 228 participants (enrolled count; ClinicalTrials.gov record NCT02488915, source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)
- Started: 2015-11 (actual) (ClinicalTrials.gov record NCT02488915, source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)
- Primary completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02488915, source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)
- Completion: 2017-09 (actual) (ClinicalTrials.gov record NCT02488915, source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)
- Results first posted: 2018-07-13 (ClinicalTrials.gov record NCT02488915, source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)
- Countries: United States; Belgium; Germany; Ireland (ClinicalTrials.gov record NCT02488915, source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02488915-2018-07-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Analysis of Revascularization in Ischemic Stroke With EmboTrap
- Acronym: ARISEII
- Condition: Stroke
- Condition: Ischemia
- Intervention (Device): EmboTrap® Revascularization Device
- Lead sponsor: Neuravi Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: bdc9c2e1b125004199f208c83e9658dab113b06f644c4fd893f952af7da0c36a
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
